NASDAQ:ELAB PMGC (ELAB) Stock Price, News & Analysis $4.54 +0.03 (+0.55%) As of 09:52 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsNews and TrendsOwnershipSEC Filings About PMGC Stock (NASDAQ:ELAB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PMGC alerts:Sign Up Key Stats Today's Range$4.41▼$4.5350-Day Range$4.52▼$13.4052-Week Range$4.40▼$2,671.20Volume5,393 shsAverage Volume381,278 shsMarket Capitalization$3.68 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California. Read More PMGC Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks21st Percentile Overall ScoreELAB MarketRank™: PMGC scored higher than 21% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingPMGC has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoveragePMGC has only been the subject of 1 research reports in the past 90 days.Read more about PMGC's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of PMGC is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of PMGC is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPMGC has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.14% of the float of PMGC has been sold short.Short Interest Ratio / Days to CoverPMGC has a short interest ratio ("days to cover") of 0.29, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in PMGC has recently decreased by 90.43%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPMGC does not currently pay a dividend.Dividend GrowthPMGC does not have a long track record of dividend growth. News and Social Media3.1 / 5News Sentiment0.93 News SentimentPMGC has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Industrials companies.News Coverage This WeekMarketBeat has tracked 2 news articles for PMGC this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for ELAB on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added PMGC to their MarketBeat watchlist in the last 30 days. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, PMGC insiders have not sold or bought any company stock.Percentage Held by Insiders0.01% of the stock of PMGC is held by insiders.Percentage Held by Institutions22.22% of the stock of PMGC is held by institutions.Read more about PMGC's insider trading history. Receive ELAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PMGC and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELAB Stock News HeadlinesPMGC Holdings Inc. (ELAB)September 12 at 11:09 PM | finance.yahoo.comNorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential ...September 1, 2026 | finance.yahoo.comDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concerns about government authority to freeze or seize private accounts. Greece raided pensions. Cyprus drained bank accounts. Poland seized retirement funds. Priority Gold has put together a free Wealth Defense Guide for Americans looking to move assets beyond potential government reach.September 14 at 1:00 AM | Priority Gold (Ad)NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic ApplicationsSeptember 1, 2026 | globenewswire.comPMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing PortfolioAugust 26, 2026 | globenewswire.comPMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting ...August 25, 2026 | finance.yahoo.comPMGC Holdings signs Orbit2Orbit term sheet for microgravity muscle researchAugust 25, 2026 | msn.comPMGC Holdings Enters Non-Binding Term Sheet for Orbit2Orbit Spaceflight Research Collaboration, U.S. Manufacturing Partnership and Strategic InvestmentAugust 25, 2026 | quiverquant.comQSee More Headlines ELAB Stock Analysis - Frequently Asked Questions How have ELAB shares performed this year? PMGC's stock was trading at $355.20 at the beginning of the year. Since then, ELAB stock has decreased by 98.7% and is now trading at $4.52. How were PMGC's earnings last quarter? PMGC Holdings Inc. (NASDAQ:ELAB) announced its earnings results on Wednesday, May, 14th. The company reported ($2,436.00) earnings per share (EPS) for the quarter. PMGC had a negative trailing twelve-month return on equity of 118.83% and a negative net margin of 522.92%. When did PMGC's stock split? PMGC shares reverse split on Tuesday, March 10th 2026.The 1-6 reverse split was announced on Wednesday, March 4th 2026. The number of shares owned by shareholders was adjusted after the market closes on Monday, March 9th 2026. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. When did PMGC IPO? PMGC (ELAB) raised $6 million in an initial public offering (IPO) on Tuesday, November 21st 2023. The company issued 1,500,000 shares at a price of $4.00 per share. Univest Securities served as the underwriter for the IPO. Who are PMGC's major shareholders? PMGC's top institutional investors include Citadel Advisors LLC (2.56%). How do I buy shares of PMGC? Shares of ELAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of PMGC own? Based on aggregate information from My MarketBeat watchlists, some other companies that PMGC investors own include BIOLASE (BIOL), CDT Equity (CDT), Cyclacel Pharmaceuticals (CYCC), Dare Bioscience (DARE), TRACON Pharmaceuticals (TCON), Tempest Therapeutics (TPST) and 22nd Century Group (XXII). Company Calendar Last Earnings5/14/2025Today9/14/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3w+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 For the last 3 weeks, ELAB's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrials Industry Aerospace & Defense Sub-IndustryAerospace & Defense Current SymbolNASDAQ:ELAB Previous SymbolNASDAQ:ELAB CIK1840563 Webelevaiskincare.com Phone866-794-4940FaxN/AEmployees18Year FoundedN/AProfitability EPS (Trailing Twelve Months)($1,305.96) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.75 million Net Margins-522.92% Pretax Margin-524.82% Return on Equity-118.83% Return on Assets-60.03% Debt Debt-to-Equity Ratio0.02 Current Ratio1.36 Quick Ratio1.30 Sales & Book Value Annual Sales$590 thousand Price / Sales6.21 Cash FlowN/A Price / Cash FlowN/A Book Value$933.34 per share Price / Book0.00Miscellaneous Outstanding Shares810,000Free Float810,000Market Cap$3.66 million OptionableN/A Beta-0.29 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:ELAB) was last updated on 9/14/2026 by MarketBeat.com Staff. From Our PartnersThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredPrint this before your next tradeBill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97. It'...Profits Run | SponsoredBlackRock and Vanguard already own THISInstitutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 ...Monument Traders Alliance | SponsoredElon Musk to Trigger Next AI Wave on November 11th?Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredThis little-known gold fund distributes cash every FridayGold pays no dividends, no interest, no yield - it just sits there. Yet investors are reportedly collecting up...Investors Alley | SponsoredWhy the Treasury still prices gold at 42 dollars an ounceThe U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PMGC Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PMGC With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
